Journal
GENES
Volume 12, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/genes12060880
Keywords
Muellerian tumors; clear cell adenocarcinoma; endometrioid adenocarcinoma; ARID1A; TERT
Categories
Funding
- Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences
Ask authors/readers for more resources
This study characterized the molecular background of Muellerian tumors of the urinary tract and identified various single nucleotide alterations and copy number alterations in these rare tumors. The absence of TERT promoter mutations and PAX8 immunohistochemical positivity were suggested as key diagnostic features for these tumors.
In the 2016 WHO classification of genitourinary tumors Muellerian tumors of the urinary tract (MTUT) comprise clear cell adenocarcinomas and endometrioid carcinomas. Since these rare tumors remained understudied, we aimed to characterize their molecular background by performing DNA- and RNA-based targeted panel sequencing. All tumors (n = 11) presented single nucleotide alterations (SNVs), with ARID1A mutations being the most prevalent (5/11, 45%). Besides frequent ARID1A mutations, loss of ARID1A protein is not a suitable marker since protein expression is (partly) preserved also in mutated cases. Copy number alterations (CNVs) were found in 64% of cases (7/11), exclusively gene amplifications. Interestingly, a functionally relevant RSPO2 gene fusion/microdeletion was discovered in the endometrioid adenocarcinoma case. Comparing our findings with mutational profiles of other tumor entities, absence of TERT promoter mutations argues for a non-urothelial origin. No similarities were also found between MTUT and kidney cancers while parallels were observed for specific SNVs with endometrial carcinomas. In conclusion, immunohistochemical PAX8-positivity and lack of TERT promoter mutations could serve as key diagnostic features in difficult cases. Thus, understanding the molecular background of these tumors helps to refine treatment options and offers the possibility of targeted therapies in cases where needed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available